Pilot study on robot assisted retinal vein cannulation with ocriplasmin infusion for central retinal vein occlusion.
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Central retinal vein occlusion
- Focus Therapeutic Use
- 13 Sep 2017 Status changed from recruiting to completed.
- 14 Aug 2017 New trial record